Asia On The Move – A Closer Look At China SFDA Personnel Changes
This article was originally published in PharmAsia News
China’s State FDA is undergoing a large-scale reorganization with scores of key personnel changes taking place as the agency transforms into the China FDA.
You may also be interested in...
A regulatory pathway set up in China post-SARS is under stress test in the latest coronavirus outbreak, while emergency measures adopted by the country's regulator mean it’s much less burdensome to obtain approvals than before.
In a drastic move, China sends top physicians from around the country to Wuhan, finally allows a WHO expert delegation to visit hospitals in the outbreak's epicenter and welcomes foreign experts.